132 related articles for article (PubMed ID: 7508172)
1. Mechanism-based approaches to inhibition of the synthesis and degradation of folate and antifolate polyglutamates.
Kalman TI
Adv Exp Med Biol; 1993; 338():639-43. PubMed ID: 7508172
[No Abstract] [Full Text] [Related]
2. Metabolism of folate glutamates in Aspergillus nidulans.
Lewandowska I; Sikora E; Szablewska I; Balińska M; Paszewski A
Adv Exp Med Biol; 1993; 338():675-7. PubMed ID: 7508173
[No Abstract] [Full Text] [Related]
3. Quinazoline thymidylate synthase inhibitors: methods for assessing the contribution of polyglutamation to their in vitro activity.
Jackman AL; Kimbell R; Brown M; Brunton L; Boyle FT
Anticancer Drug Des; 1995 Oct; 10(7):555-72. PubMed ID: 7495479
[TBL] [Abstract][Full Text] [Related]
4. Folate analog nonsubstrates and inhibitors of folylpolyglutamate synthetase as potential cancer chemotherapy drugs.
McGuire JJ; Piper JR; Coward JK; Galivan J
NCI Monogr; 1987; (5):139-44. PubMed ID: 2448652
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of gamma-glutamyl hydrolases in human cells by 2-mercaptomethylglutaric acid.
Whitehead VM; Kalman TI; Vuchich MJ
Biochem Biophys Res Commun; 1987 Apr; 144(1):292-7. PubMed ID: 2437910
[TBL] [Abstract][Full Text] [Related]
6. gamma-Glutamyl hydrolase and folylpolyglutamate synthetase activities predict polyglutamylation of methotrexate in acute leukemias.
Longo GS; Gorlick R; Tong WP; Lin S; Steinherz P; Bertino JR
Oncol Res; 1997; 9(5):259-63. PubMed ID: 9306433
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.
Pinto JT; Suffoletto BP; Berzin TM; Qiao CH; Lin S; Tong WP; May F; Mukherjee B; Heston WD
Clin Cancer Res; 1996 Sep; 2(9):1445-51. PubMed ID: 9816319
[TBL] [Abstract][Full Text] [Related]
8. Glutamylation of methotrexate in hepatoma cells in vitro: regulation and the development of specific inhibitors.
Galivan J; Nimec Z; Coward JK; McGuire JJ
Adv Enzyme Regul; 1985; 23():13-23. PubMed ID: 2416193
[TBL] [Abstract][Full Text] [Related]
9. Exploitation of folate and antifolate polyglutamylation to achieve selective anticancer chemotherapy.
McGuire JJ; Tsukamoto T; Hart BP; Coward JK; Kalman TI; Galivan J
Invest New Drugs; 1996; 14(3):317-23. PubMed ID: 8958187
[TBL] [Abstract][Full Text] [Related]
10. Acquisition of resistance to antifolates caused by enhanced gamma-glutamyl hydrolase activity.
Rhee MS; Wang Y; Nair MG; Galivan J
Cancer Res; 1993 May; 53(10 Suppl):2227-30. PubMed ID: 7683570
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic synthesis of folate and antifolate polyglutamates with Escherichia coli folylpolyglutamate synthetase.
Hanlon MH; Ferone R; Weaver K; Ray P
Anal Biochem; 1994 Feb; 216(2):345-51. PubMed ID: 7513973
[TBL] [Abstract][Full Text] [Related]
12. Folylpolyglutamate synthetase inhibition and cytotoxic effects of methotrexate analogs containing 2,omega-diaminoalkanoic acids.
McGuire JJ; Hsieh P; Franco CT; Piper JR
Biochem Pharmacol; 1986 Aug; 35(15):2607-13. PubMed ID: 2427084
[TBL] [Abstract][Full Text] [Related]
13. Insulin-dependent suppression in glutamyl hydrolase activity and elevated cellular methotrexate polyglutamates.
Galivan J; Rhee MS
Biochem Pharmacol; 1995 Nov; 50(10):1659-63. PubMed ID: 7503769
[TBL] [Abstract][Full Text] [Related]
14. Hydrolytic cleavage of methotrexate gamma-polyglutamates by folylpolyglutamyl hydrolase derived from various tumors and normal tissues of the mouse.
Samuels LL; Goutas LJ; Priest DG; Piper JR; Sirotnak FM
Cancer Res; 1986 May; 46(5):2230-5. PubMed ID: 2421872
[TBL] [Abstract][Full Text] [Related]
15. Metabolic turnover of methotrexate polyglutamates in lysosomes derived from S180 cells. Definition of a two-step process limited by mediated lysosomal permeation of polyglutamates and activating reduced sulfhydryl compounds.
Barrueco JR; O'Leary DF; Sirotnak FM
J Biol Chem; 1992 Aug; 267(22):15356-61. PubMed ID: 1379226
[TBL] [Abstract][Full Text] [Related]
16. The role of methotrexate and dihydrofolate polyglutamates in the enhancement of fluorouracil action by methotrexate.
Fernandes DJ; Moroson BA; Bertino JR
Cancer Treat Rep; 1981; 65 Suppl 1():29-35. PubMed ID: 6173121
[TBL] [Abstract][Full Text] [Related]
17. Increased activity of gamma-glutamyl hydrolase in human sarcoma cell lines: a novel mechanism of intrinsic resistance to methotrexate (MTX).
Li WW; Waltham M; Tong W; Schweitzer BI; Bertino JR
Adv Exp Med Biol; 1993; 338():635-8. PubMed ID: 7508171
[No Abstract] [Full Text] [Related]
18. Acute monocytic leukemia: a myeloid leukemia subset that may be sensitive to methotrexate.
Göker E; Kheradpour A; Waltham M; Banerjee D; Tong WP; Elisseyeff Y; Bertino JR
Leukemia; 1995 Feb; 9(2):274-6. PubMed ID: 7532768
[TBL] [Abstract][Full Text] [Related]
19. Capillary electrophoresis of methotrexate polyglutamates and its application in evaluation of gamma-glutamyl hydrolase activity.
Waltham MC; Lin S; Li WW; Göker E; Gritsman H; Tong WP; Bertino JR
J Chromatogr B Biomed Sci Appl; 1997 Feb; 689(2):387-92. PubMed ID: 9080326
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human dihydrofolate reductase by antifolyl polyglutamates.
Kumar P; Kisliuk RL; Gaumont Y; Freisheim JH; Nair MG
Biochem Pharmacol; 1989 Feb; 38(3):541-3. PubMed ID: 2465007
[No Abstract] [Full Text] [Related]
[Next] [New Search]
